```html

Xanthoma (Fatty Skin Nodules)

What is Xanthoma (fatty skin nodules)?

Xanthomas are firm, yellow‑orange, often raised nodules or plaques that appear on the skin or tendons. They are composed of lipid‑laden macrophages (called foam cells) that accumulate in the dermis. While they can be purely cosmetic, xanthomas frequently signal an underlying disorder of lipid metabolism or another systemic disease.

These lesions may vary in size from a few millimetres to several centimetres, and they can appear anywhere on the body, but common sites include the elbows, knees, buttocks, hands, eyelids (xanthelasma), and tendons (tendon xanthoma). Because they are visible and sometimes symptomatic (itchy or painful), recognizing them early can lead to timely investigation of potentially serious health conditions.

Common Causes

Xanthomas are not a disease themselves; they are a cutaneous manifestation of metabolic or hematologic problems. The most frequent causes include:

• Familial Hypercholesterolemia (FH) – an inherited defect in LDL‑receptor function leading to very high LDL‑cholesterol.
• Familial Combined Hyperlipidemia – elevated LDL‑cholesterol and triglycerides.
• Familial Dysbetalipoproteinemia (Type III hyperlipoproteinemia) – accumulation of remnant lipoproteins.
• Secondary hyperlipidemia due to diabetes mellitus, hypothyroidism, nephrotic syndrome, or chronic liver disease.
• Cholesterol ester storage disease (CESD) / LIPA deficiency – a rare lysosomal storage disorder.
• Primary biliary cholangitis (PBC) – can cause xanthelasma and other cutaneous xanthomas.
• Gaucher disease – another lysosomal storage disease that can present with cutaneous xanthomas.
• Drug‑induced lipid abnormalities (e.g., protease inhibitors, glucocorticoids, thiazide diuretics).
• Obstructive biliary disease – cholestasis may raise serum cholesterol and cause xanthelasma.
• Autoimmune or inflammatory conditions – rare cases of eruptive xanthomas seen in severe hypertriglyceridemia secondary to systemic inflammation.

Associated Symptoms

While xanthomas themselves are usually painless, they often coexist with other clinical clues that point toward the underlying disorder:

• Dry, yellowish plaques on the eyelids (xanthelasma) – commonly associated with hyperlipidemia.
• Chest pain or early‑onset cardiovascular disease, especially in familial hypercholesterolemia.
• Fatigue, swelling (edema), or proteinuria in nephrotic syndrome.
• Weight loss, abdominal pain, or hepatomegaly in liver disease.
• Polydipsia, polyuria, and blurred vision in uncontrolled diabetes.
• Diffuse itching (pruritus) that can accompany cholestatic liver disease.
• Muscle cramps or weakness if tendon xanthomas impair function.
• Family history of early heart attacks or stroke.

When to See a Doctor

Because xanthomas may herald serious metabolic disorders, you should schedule a medical evaluation if you notice:

• Any new yellow‑orange nodule or plaque on the skin, especially if it enlarges or multiplies.
• Xanthomas appearing before age 30, or a rapid increase in size.
• Family members with known lipid disorders or early‑onset heart disease.
• Associated symptoms such as chest pain, shortness of breath, unexplained fatigue, or swelling.
• Changes in vision, persistent itching, or jaundice (which may suggest liver involvement).

Early assessment enables risk‑reduction strategies that can prevent heart attacks, strokes, and organ damage.

Diagnosis

1. Clinical Examination

The dermatologist or primary‑care clinician will first document the distribution, size, and texture of the lesions. Photographs are often taken for baseline comparison.

2. Laboratory Tests

• Lipid panel – fasting total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Liver function tests – AST, ALT, alkaline phosphatase, bilirubin.
• Renal function – serum creatinine, urine protein/creatinine ratio.
• Thyroid studies – TSH, free T4.
• Genetic testing for familial hypercholesterolemia (LDLR, APOB, PCSK9) if indicated.
• Rarely, specialized tests (e.g., serum lipoprotein electrophoresis) for Type III hyperlipoproteinemia.

3. Imaging & Specialized Studies

• Ultrasound or MRI of tendons may be used to evaluate deep tendon xanthomas.
• Coronary calcium scoring or carotid ultrasound to assess atherosclerotic burden in high‑risk patients.

4. Skin Biopsy (rare)

In ambiguous cases, a punch biopsy can confirm the presence of foam cells and rule out other dermatoses.

Treatment Options

1. Address the Underlying Metabolic Disorder

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line for lowering LDL‑C.
• Ezetimibe – added when statin monotherapy is insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab) – especially for homozygous FH or statin‑intolerant patients.
• Fibrates (gemfibrozil, fenofibrate) – useful in severe hypertriglyceridemia.
• Niacin – can raise HDL‑C and lower triglycerides, but limited by side effects.
• Omega‑3 fatty acid supplements – EPA/DHA formulations help lower triglycerides.
• Management of secondary causes: optimize diabetes control, treat hypothyroidism, address nephrotic syndrome, modify offending drugs.

2. Direct Management of the Lesions

• Observation – many small xanthomas regress once lipid levels are normalized.
• Laser therapy (e.g., CO₂ or pulsed‑dye laser) – effective for superficial xanthelasma.
• Surgical excision – considered for large, painful, or function‑limiting nodules.
• Cryotherapy – occasionally used for small eruptive lesions.

3. Lifestyle Modifications

• Diet – adopt a heart‑healthy Mediterranean diet rich in fruits, vegetables, whole grains, nuts, and oily fish; limit saturated fats, trans fats, and refined sugars.
• Physical activity – at least 150 minutes of moderate‑intensity aerobic exercise per week.
• Weight management – achieve and maintain a healthy BMI (18.5–24.9 kg/m²).
• Alcohol moderation – especially important in hypertriglyceridemia.
• Smoking cessation – reduces cardiovascular risk dramatically.

Prevention Tips

While you cannot always prevent genetically driven lipid disorders, many steps can reduce the likelihood of developing xanthomas or limit their progression:

• Screen lipid levels at least once every 5 years, or earlier if you have risk factors (family history, obesity, diabetes).
• Follow a low‑saturated‑fat diet from childhood; involve a dietitian if needed.
• Maintain regular exercise and a healthy weight.
• Control blood sugar and blood pressure aggressively.
• Take prescribed lipid‑lowering medication consistently and attend follow‑up labs.
• Avoid or discuss with your physician the long‑term use of medications known to raise lipids.
• For patients with known genetic disorders, consider cascade screening of first‑degree relatives.

Emergency Warning Signs

Key Take‑aways

Xanthomas are visible clues that the body’s lipid handling is out of balance. By recognizing the lesions early, obtaining a thorough evaluation, and addressing the root cause, most patients can dramatically lower their risk of cardiovascular disease and often see the skin findings improve. If you notice any suspicious yellow‑orange nodules, especially with a family history of high cholesterol or heart disease, schedule a visit with your primary‑care provider or a dermatologist promptly.

References:

• Mayo Clinic. “Xanthoma.” mayoclinic.org
• National Heart, Lung, and Blood Institute (NHLBI). “Familial Hypercholesterolemia.” nlm.nih.gov
• American Heart Association. “Understanding Cholesterol and Triglycerides.” heart.org
• CDC. “Lipoprotein Disorders.” cdc.gov
• Cleveland Clinic. “Xanthelasma – Yellow Plaques Around the Eyes.” clevelandclinic.org
• World Health Organization. “Guidelines for the Management of Dyslipidaemias.” 2021.

```